Related Experiment Video
Updated: Mar 23, 2026

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
Published on: May 21, 2018
Exploring Synergistic Anti-Psoriatic Potential of Bioactive Compounds Tyrosol and Farnesol through In-Silico and In
Pankaj Singh Patel1, Rajnish Srivastava2, Naveen Singh2
1Department of Pharmaceutical Sciences, Mohanlal Sukhadia University, Udaipur, Rajasthan, India.
Tyrosol and Farnesol show promise for psoriasis treatment by reducing inflammation and oxidative stress. Their combined use enhances these beneficial effects, suggesting potential therapeutic applications.
Area of Science:
- Dermatology
- Pharmacology
- Biochemistry
Background:
- Psoriasis is a chronic inflammatory skin condition influenced by genetic, immune, and environmental factors.
- Understanding the molecular mechanisms underlying psoriasis is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the anti-psoriatic and antioxidant properties of Tyrosol and Farnesol.
- To evaluate the binding potential of Tyrosol and Farnesol to key psoriasis-associated proteins.
Main Methods:
- Molecular docking simulations using AutoDock were employed to assess compound-protein interactions.
- In vitro antioxidant assays (DPPH, nitric oxide, hydrogen peroxide scavenging) were performed.
Main Results:
- Tyrosol and Farnesol demonstrated significant binding affinities to psoriasis-related targets like RORγt, IRAK4, and cPLA2.
- Both compounds exhibited notable antioxidant activities, with their combination showing enhanced free radical scavenging capacity.
Conclusions:
- The findings suggest Tyrosol and Farnesol can modulate key inflammatory and oxidative pathways implicated in psoriasis.
- These compounds, particularly in combination, represent potential therapeutic agents for managing psoriasis.
More Related Videos
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase